LSTA

Lisata Therapeutics Inc

Stock NASDAQ – Stock Market Prices, News & Analysis

American biopharmaceutical company focused on developing targeted therapies for the treatment of cancer.

$ 3.21
16.73 %

Lisata Therapeutics Inc

$ 3.21
16.73 %
LSTA

American biopharmaceutical company focused on developing targeted therapies for the treatment of cancer.

Price history of Lisata Therapeutics Inc
Price history of Lisata Therapeutics Inc

Performance & Momentum

6 Months 62.77 %
1 Year 82.27 %
3 Years 25.16 %
5 Years 82.77 %

Strategic Analysis

Lisata Therapeutics Inc • 2026

Lisata Therapeutics Inc positions itself as an innovative player in the American biopharmaceutical sector, specializing in the development of targeted therapies for cancer treatment. Its model is based on an advanced medical research approach aimed at providing differentiated and high-value oncological treatments.

Strengths
  • Focus on oncology, a promising segment with strong demand for therapeutic innovation
  • Expertise in targeted treatments, enhancing the precision and efficacy of proposed therapies
  • Sustained innovation capacity supported by in-depth medical research
Weaknesses
  • Significant historical volatility, particularly in the medium term
  • Recent lack of notable news, which may limit short-term visibility
Momentum

Current momentum is strong, supported by notable performance in recent months, reflecting renewed investor interest in its clinical prospects. This positive dynamic offers an attractive window to capitalize on the advancement of its oncological programs.

Similar stocks to Lisata Therapeutics Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone